← Back to catalogue

Elecsys Anti-HCV II Immunoassay Test System

FDA PMA

Class II (US FDA PMA)

PMA P140021

by Roche Diagnostics Operations, Inc.

Identity

Trade Name
ELECSYS ANTI-HCV II IMMUNOASSAY, ELECSYS PRECICONTROL ANTI-HCV FDA PMA
Generic Name
Assay, enzyme linked immunosorbent, hepatitis c virus FDA PMA

Identifiers

PMA Number
P140021 FDA PMA
FDA Product Code
MZO FDA PMA

Classification

Device Class
Class II FDA PMA
Legislation / Framework
21 CFR Part 866.3169 FDA PMA
Regulation Number
866.3169 FDA PMA
Advisory Committee
Microbiology FDA PMA
FDA Decision
APRL FDA PMA

The Elecsys Anti-HCV II Immunoassay Test System is an enzyme-linked immunosorbent assay (ELISA) intended for the in vitro qualitative detection of antibodies to hepatitis C virus (HCV) in human serum and plasma. It employs an electrochemiluminescence immunoassay (ECLIA) technology to identify HCV antibodies in adult and pediatric samples aged 18 months through 21 years, aiding in the presumptive diagnosis of HCV infection when used alongside clinical information and other laboratory results.

This system is designed for use on the Roche Cobas E 601 immunoassay analyzer, with the Elecsys PreciControl Anti-HCV serving as a quality control measure for the Elecsys Anti-HCV II Immunoassay on the Cobas E 601 and Cobas E 602 analyzers. Supplied as a reagent kit, the device is intended for laboratory use and requires compliance with standard microbiological practices. Approval for the Elecsys Anti-HCV II Immunoassay and Elecsys PreciControl Anti-HCV was granted under an FDA Premarket Approval (PMA) application.

This description and any FAQs above were generated automatically from registry data and have not been verified by the manufacturer or by deviCERTS. Always check the official registry entry and the manufacturer's instructions for use before relying on them.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Active

FDA_PMA

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA PMA P140021 24 fields · synced Oct 6, 2026